Combination of Anti-miRNAs Oligonucleotides with Low Amounts of Chemotherapeutic Agents for Pancreatic Cancer Therapy-Reference-Cited by-同舟云学术

Combination of Anti-miRNAs Oligonucleotides with Low Amounts of Chemotherapeutic Agents for Pancreatic Cancer Therapy

Published:2017-10-31 Issue: Volume: Page:135-154
ISSN:1064-3745
Container-title:MicroRNA and Cancer
language:
Short-container-title:

Author:

Passadouro Marta,Faneca Henrique

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-7435-1_11

Reference17 articles.

1. Saif MW (2011) Pancreatic neoplasm in 2011 : an update. J Pancreas 12:316–321

2. Hidalgo M, Von Hoff DD (2012) Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas. Clin Cancer Res 18:4249–4256

3. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

4. Marco MDI, Cicilia RDI, Macchini M et al (2010) Metastatic pancreatic cancer : is gemcitabine still the best standard treatment ? (Review). Oncol Rep 23:1183–1192

5. Mardin WA, Mees ST (2009) MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma? Ann Surg Oncol 16:3183–3189

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on microRNAs as molecular markers in pancreatic cancer: a narrative review;Journal of Gastrointestinal Oncology;2022-08

2. Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer;Current Pharmaceutical Biotechnology;2020-01-07

3. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments;Expert Opinion on Drug Discovery;2019-11-19

4. A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model;OncoTargets and Therapy;2018-12